Royalty Pharma plc (RPRX)
| Previous close | 27.82 |
| Open | 27.90 |
| Bid | 27.91 x 400 |
| Ask | 28.00 x 400 |
| Day's range | 27.60 - 28.00 |
| 52-week range | 25.92 - 35.76 |
| Volume | |
| Avg. volume | 2,745,059 |
| Market cap | 16.695B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 11.05 |
| EPS (TTM) | 2.53 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | 0.84 (3.02%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | 45.50 |
Simply Wall St.Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
The board of Royalty Pharma plc ( NASDAQ:RPRX ) has announced that it will pay a dividend of $0.21 per share on the...
GlobeNewswireRoyalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events/ to obtain conference call information an
- GlobeNewswire
Royalty Pharma Declares Second Quarter 2024 Dividend
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on June 14, 2024, to shareholders of record at the close of business on May 17, 2024. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industr
